(Center for Genomic Regulation) A research effort led by Eulàlia Martí at the Centre for Genomic Regulation reveals new molecular mechanisms of Huntington's chorea. The results, recently published in the Journal of Clinical Investigation, question the approaches used up to now for treatment of the disease. They also point to messenger RNA as a key pathogenic component that will make it possible to define new therapeutic strategies.
The messenger in Huntington’s disease
Please login to join discussion
POPULAR NEWS
-
NYU Abu Dhabi researchers identify unique survival strategies adopted by fish in the world’s warmest waters
-
CHOP experts describe types of rashes associated with MIS-C
-
Scientists discover that a protein associated with neurodegenerative diseases is also linked to childhood brain cancer
-
Automatic design of metaheuristics: The future of optimization?